Binge Eating Disorder News and Research

RSS

Binge Eating Disorder is characterized by frequent episodes of binge eating. Individuals feel loss of control during these binge episodes. The binge eating can lead to serious health consequences such as obesity, diabetes, hypertension (high blood pressure) and heart disease.

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.

23 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22.

20 May 2013

Biological Psychiatry special issue tackles the question on food addiction

Biological Psychiatry is proud to announce this week's publication of a special issue focusing on the question of food as an addiction.

23 Apr 2013

Lightlake to present Phase II clinical trial results of opioid antagonist nasal spray at APA Annual Meeting

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing addiction treatments, announced today that a scientific abstract based on results of the Company's Phase II clinical trial of its opioid antagonist nasal spray treatment for patients with Binge Eating Disorder has been accepted for presentation at the American Psychiatric Association Annual Meeting taking place in San Francisco, California, May 18-22, 2013.

27 Mar 2013

APS to present scientific abstracts at Experimental Biology 2013

The American Physiological Society is one of six scientific societies sponsoring the meeting Experimental Biology 2013, being held April 20-24, 2013 at the Boston Convention and Exhibition Center, in Boston, Mass.

21 Mar 2013

Eating disorders common in adolescents attending emergency department

A significant percentage of adolescents attending hospital emergency response departments have eating disorders, suggest results from a US study.

22 Nov 2012

Mental Health experts examine classifications of children's illness; Eating disorders patients worry about coverage

The Wall Street Journal looks at the effort to include kids' problems in the newest revision of psychiatrists' diagnostic manual. Also, KHN offers a story about the debate over health insurance for people with eating problems.

20 Oct 2012

First Edition: October 19, 2012

Today's headlines include reports about how Medicare and women's health issues are playing in a number of House and Senate races.

19 Oct 2012

Social phobia prevalent in OCD patients

Social phobia is common among patients with obsessive compulsive disorder and frequently co-occurs with other related disorders, researchers report.

21 Aug 2012

Lightlake announces final data from naloxone nasal spray Phase II study on Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company developing modern addiction treatments based on its expertise using opioid antagonists, announced today compelling final data from a Phase II study of the Company's proprietary opioid antagonist naloxone nasal spray treatment for patients with Binge Eating Disorder (BED).

9 Aug 2012

Blocking Sigma-1 receptor can reduce binge eating

Researchers from Boston University School of Medicine (BUSM) have demonstrated in experimental models that blocking the Sigma-1 receptor, a cellular protein, reduced binge eating and caused binge eaters to eat more slowly.

21 Jun 2012

Chicago psychological center serves as model for treatment of binge eating

As experts discuss major changes in binge eating, a Chicago psychological center serves as a model for treatment of the most common eating disorder.

5 Jun 2012

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.

27 Apr 2012

Study explores the processing of body pictures in binge eating

An investigation published in the current issue of Psychotherapy and Psychosomatics explores the processing of body pictures in binge eating.

29 Mar 2012

Potential efficacy of specialized psychotherapy in bulimia nervosa and binge eating disorder

An investigation published in the current issue of Psychotherapy and Psychosomatics addresses the potential efficacy of a specialized psychotherapy in bulimia nervosa and binge eating disorder.

15 Mar 2012

Psychiatric disorders definitions to be revised

The definition of depression is proposed to be changed and now the diagnosis would characterize grieving as a disorder and greatly increase the number of people treated for it.

26 Jan 2012

Lightlake to begin opioid antagonist derived nasal spray Phase II trials in Binge Eating Disorder

Lightlake Therapeutics Inc., an early stage biopharmaceutical company currently developing a nasal spray for the treatment of overweight and obese patients with Binge Eating Disorder, today announced that its patient testing stage of the Phase II clinical trials will start August 26th, 2011

25 Aug 2011

ADA releases new position paper, 'Nutrition Intervention in the Treatment of Eating Disorders'

As one of the most complicated sets of illnesses to treat, eating disorders have mental health, as well as medical and nutritional, aspects. While treatment by a multidisciplinary health-care team is considered the best practice, there is considerable debate over how to most effectively treat eating disorders and who should be on a treatment team.

2 Aug 2011

Clinical symptoms of food addiction are similar to symptoms of drug addiction

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that people can become dependent on highly palatable foods and engage in a compulsive pattern of consumption, similar to the behaviors we observe in drug addicts and those with alcoholism.

13 Jul 2011